Abstract
Background: Given the minimal capacity and sometimes the failure of the mammalian nervous system to regenerate and repair itself after damage, strategies are required to help enhance this regenerative process. Adipose-derived Mesenchymal Stem Cells (ADMSCs) are likely candidates to assist in the recovery process due to their ability to differentiate into neural cells. Successful implementation of this intervention in a clinical setting would increase the rate of recovery following traumatic brain injury. Review: Various strategies have been attempted to differentiate ADMSCs into neural cells for clinical use. Such methods have not been entirely successful in the development of functioning special-ized cells for subsequent practical use. Therefore, the implementations of this differentiation tech-nique in the clinical trial have not been effective. In this article, the potential of differentiating ADMSCs into neural cells and the various methods employed, including biological induction, chemical induction and photobiomodulation (PBM) will be discussed, where the combined use of transducers and PBM for neural differentiation of ADMSCs is also deliberated. Conclusion: PBM shows promise as an avenue for effective ADMSCs differentiation into neural cells and their proliferation. Applying PBM with optimized biological factors and chemical induc-ers may prove to be an effective tool for clinical application.
Original language | English |
---|---|
Pages (from-to) | 307-322 |
Number of pages | 16 |
Journal | Current Stem Cell Research and Therapy |
Volume | 16 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2021 |
Keywords
- Adipose-derived mesenchymal stem cells
- Chemical inducers
- Differentiation
- Growth fac-tors
- Neural regeneration
- Photobiomodulation
ASJC Scopus subject areas
- Medicine (miscellaneous)